BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 34437579)

  • 1. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
    PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
    Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
    Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.
    Stephenson T; Pinto Pereira SM; Nugawela MD; McOwat K; Simmons R; Chalder T; Ford T; Heyman I; Swann OV; Fox-Smith L; Rojas NK; Dalrymple E; Ladhani SN; Shafran R;
    PLoS One; 2023; 18(3):e0277704. PubMed ID: 36877677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.
    Yang Y; Hu X; Xiong L; Fu P; Feng W; Li W; Zhang L; Sun F
    BMC Infect Dis; 2021 Feb; 21(1):141. PubMed ID: 33535989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long COVID outcomes following omicron wave in non-hospital population.
    Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
    Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?
    Schneider A; Kirsten H; Lordick F; Lordick F; Lübbert C; von Braun A
    PLoS One; 2021; 16(2):e0246312. PubMed ID: 33534829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
    Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
    PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of laparoscopically-confirmed endometriosis with long COVID-19: a prospective cohort study.
    Wang S; Farland LV; Gaskins AJ; Mortazavi J; Wang YX; Tamimi RM; Rich-Edwards JW; Zhang D; Terry KL; Chavarro JE; Missmer SA
    Am J Obstet Gynecol; 2023 Jun; 228(6):714.e1-714.e13. PubMed ID: 36972892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study.
    Pan L; Wang R; Yu N; Hu C; Yan J; Zhang X; Wang T; Hao J; Gao F; Liu T; Wang J; Liu X; Mu M; Huang W; Guo Y; Lv C; Wang X; Tu L; Wan K; Xu G
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1245-1252. PubMed ID: 33447913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
    Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
    JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 reinfections among naturally infected and vaccinated individuals.
    Rahman S; Rahman MM; Miah M; Begum MN; Sarmin M; Mahfuz M; Hossain ME; Rahman MZ; Chisti MJ; Ahmed T; Arifeen SE; Rahman M
    Sci Rep; 2022 Jan; 12(1):1438. PubMed ID: 35082344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
    Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
    J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
    Bianco MR; Modica DM; Drago GD; Azzolina A; Mattina G; De Natale M; Rossi G; Amata M; Canzoneri G; Manganaro G; Di Gregorio F; Russo R; Pricoco S; Saita V; Allegra E
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):182S-185S. PubMed ID: 33350319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.